<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218566</url>
  </required_header>
  <id_info>
    <org_study_id>11373</org_study_id>
    <nct_id>NCT03218566</nct_id>
  </id_info>
  <brief_title>Evaluating the Safety and Efficacy of the Indigo Aspiration System in Acute Submassive Pulmonary Embolism</brief_title>
  <acronym>EXTRACT-PE</acronym>
  <official_title>A Prospective, Multicenter Trial to Evaluate the Safety and Efficacy of the Indigo Aspiration System in Acute Submassive Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penumbra Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penumbra Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the safety and efficacy of the Indigo Aspiration System for aspiration
      mechanical thrombectomy in patients with acute submassive pulmonary embolism (PE)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 22, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RV/LV ratio</measure>
    <time_frame>from baseline to 48 hours</time_frame>
    <description>reduction in RV/LV ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major adverse events</measure>
    <time_frame>within 48 hours</time_frame>
    <description>device related, major bleeding, device related SAEs</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Single Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single Arm - Use of Indigo Aspiration System (mechanical thrombectomy) to treat pulmonary embolism</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Indigo Aspiration System</intervention_name>
    <description>use of mechanical thrombectomy to treat pulmonary embolism</description>
    <arm_group_label>Single Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic acute PE with duration of 14 days or less.

          -  Systolic BP ≥90 mmHg with evidence of dilated RV with an RV/LV ratio &gt;0.9 Patient is
             18 years of age or older

        Exclusion Criteria:

          -  Systolic BP &lt;90mmHg for 15min or the requirement of inotropic support to maintain
             systolic BP ≥90 mmHg

          -  Pulmonary hypertension with peak PA &gt;70 mmHg by right heart catheterization

          -  History of severe or chronic pulmonary hypertension

          -  Fi02 requirement &gt;40% or &gt;6 LPM to keep oxygen saturations &gt;90%

          -  Hematocrit &lt;28%

          -  Platelets &lt;100,000µL

          -  Serum creatinine &gt;1.8 mg/dL

          -  INR &gt;3

          -  aPTT &gt;50 seconds on no anticoagulation

          -  History of heparin-induced thrombocytopenia (HIT)

          -  Major trauma within last 7 days

          -  Cardiovascular or pulmonary surgery within last 7 days

          -  Cancer which requires active chemotherapy

          -  Known serious, uncontrolled sensitivity to radiographic agents

          -  Life expectancy &lt;30 days

          -  Female who is pregnant or breastfeeding

          -  Intracardiac Thrombus

          -  Current participation in another investigational study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Priya Guyadeen</last_name>
    <phone>510-995-4440</phone>
    <email>pguyadeen@PENUMBRAINC.COM</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michaella Corso</last_name>
    <phone>510-995-2079</phone>
    <email>mcorso@penumbrainc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baptist Hospital of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Schiro, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pulmonary embolism</keyword>
  <keyword>clot</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

